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Summary
Using a transgenic mouse model we show that increased intrathymic expression of interleukin
4 (IL4) significantly perturbs the development of thymocytes. Transgenic double-positive
(CD4+CD8+) thymocytes, which are present in dramatically reduced numbers, exhibit increased
T cell receptor (TCR)expression and increased mobilization ofcalcium mediated by these receptors.
In contrast, transgenic single-positive (CD4+CD8- and CD4- CD8+) thymocytes and periph-
eral T cells exhibit decreased TCRmediated calcium mobilization. The development of CD4-
CD8+ thymocytes is significantly perturbed by 114 expressed in vivo; only peripheral CD4+
T cells are found in significant numbers in transgenic mice, while CD4- CD8+ thymocytes are
present in increased numbers, apparently because of their failure to emigrate to the periphery.
In contrast to these selective effects on T cell development, no significant differences in the numbers
ofB cells or mast cells, or in the plasma levels of IgE and IgG1 are observed between transgenic
and control mice. These observations suggest that 114 in vivo exerts its major effects locally
rather than systemically, even when its expression is constitutively increased.
I
1,4 is a cytokine secreted by T cells and mast cells which
has pleotropic effects on a wide variety of hematopoietic
cell types in vitro (1). Originally described as a growth factor
for partially activated B cells (2), IIr4 has subsequently been
shown to promote T cell and mast cell growth as well (3-5),
and to have multiple effects on the differentiation of mature
lymphocytes (1, 6-10). These 11,4-mediated effects include
increased class II MHC surface expression and IgG1 and IgE
production by B cells (6-8), enhanced generation of T cell-
mediated cytotoxicity (9), and the induction of surface CD8
expression by CD4+ T cell clones (10) . Although these
findings suggest that HA regulates multiple aspects of antigen-
specific immunity, the production of IgE by B-lineage cells
is the only lymphocyte-mediated function which has clearly
been shown to depend on the production of IL-4 in vivo (11,
12).
The expression ofIL4 mRNA by thymocytesin vivo during
fetal ontogeny (13), and the secretion of 11,4 by fetal and adult
CD4-CD8- (double-negative) thymocytes after in vitro ac-
tivation (14, 15), suggest that this cytokine may also have
a role in normal T cell development. A number of in vitro
studies have documented that IL4 can either augment or in-
hibit the growth of isolated thymocytes, depending on the
cell population studied, the stimulus used for cell activation,
and which other cytokines are present (15-20). Studies of
CD4-CD8' thymocyte differentiation in vitro indicate that
11,4 may favor the development of double-negative or CD8+
cells bearing .y/S rather than a/(3 T cell receptors (16, 21).
However, these studies do not satisfactorily address the func-
tion of IL4 in an intact intrathymic context; it is likely that
114 and other cytokines significantly influence other com-
ponents of the thymic microenvironment which provide es-
sential signalsregulating thymocyte growth, differentiation,
and selection. Therefore, we have generated transgenic mice
in which 11,4 is selectively expressed intrathymically. Such
animals exhibit profound but selective disturbances in thymo-
cyte development, including an accumulation of thymocytes
bearing high levels of TCR-oi//3 and a CD4 - CD8+ surface
phenotype. Remarkably, intrathymic 11.4 expression does not
alter the normal pattern of Ig isotypes in plasma or B cell
or mast cell abundance. These results suggest that 11,4 can
behave as a natural regulator of thymocyte maturation, but
that its effects are exerted locally rather than systemically.
Materials and Methods
Preparation o.fthelck-IL4 Construct.
￿
The kk-IL4 construct (Fig.
1) was made by inserting a full-length murine IL4 cDNA clone,
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Volume 173 January 1991 89-1000.7-kb BamH1 fragment (22), into the calfintestinal phosphatase-
treated BarnHI site of an expression vector, p1017 (Chaffin,K. E.,
C. R. Beals, TM. Wilkie, K. A. Forbush,M. I . Simon, andR.M.
Perlmutter, manuscript submitted for publication) using standard
techniques (23) . In the final construct, themurine IL-4cDNA seg-
ment was located 3' to a 3.2-kb murine proximal lckpromoter seg-
ment at +37 with respect to the transcription start site (24, 25),
and 5' to a2.1-kbBamH1-EcoRI fragment of the humangrowth
hormone (hGH)' gene (26) . The IL-4 cDNA was the generous
gift of Dr. E. Severinson (University of Stockholm, Stockholm,
Sweden) .
Generation ofIck-IL4 Transgenic Mice.
￿
A6.0-kbNodfragment
containing the lck-IL4 constructwas purified by agarose gel elec-
trophoresis onto DEAE-nitrocellulose paper (23) and diluted to
2 ng/ml in 10 mM Tris, 0.1 mM EDTA, pH 7.5 . Aliquots of this
preparationwere injected into the pronuclei of C57BL/6JXDBA/2J
FZ hybrid mouse zygotes using standard techniques (27) . Viable
zygoteswere then transferred into the oviducts ofrecipient pseudo-
pregnant females . Mice bearing the constructwere detected by hy-
bridization ofblotted tailDNA as previously described (25), using
a 32P-labeled 0.6-kb Smal-EcoRI hGH fragment (26) as a probe.
Tansgene-positive lines were propagated by backcrossing founder
animals with C57BL/6J mice . In all experiments, nontransgenic
littermates served as age-matched, wild-type controls . Original
strains of C57BL/6J and DBA/2J mice were obtained from The
Jackson Laboratories (Bar Harbor, ME) .
RNA Blots.
￿
Total RNA was isolated from tissue or cell prepa-
rations by the guanidinium-isothiocyanate/CsCl method (28) . RNA
was quantitated spectrophotometrically, electrophoresed in 1%
agarose gels made in 2.2 M formaldehyde, and blotted as previ-
ously described (29) . Hybridization and washing conditions were
those previously described for 12p-labeledDNA probes (30) . The
murine 11,4 probe, which consisted ofa0.6-kb BamHI-SspI cDNA
fragment (22), was "P-labeled using the random hexamer priming
method (31) .
Cell Isolationand Stimulation .
￿
Single-cell suspensions of thymo-
cytes andLN cells were prepared by finely mincing or teasing these
tissues . To isolate spleen mononuclear cells, tissue was first disrupted
with a fine-meshed sieve, and the mononuclear cell fraction was
subsequently purified by Ficoll-Hypaque density gradient centrifu-
gation (32) . Bone marrowcells werecollectedby irrigation offemurs
andhumeri from euthanized mice (33) .As necessary, contaminating
red cells were removed by hypotonic NH4Cl treatment (33) .
11,4 Assay.
￿
Thymocytes, splenocytes, or bone marrow cells (5
x 10 6/ml) from transgenic mice or control littermates were cul-
tured inCT4S medium (34) (RPMI 1640 [Mediatech, Washington,
DC] with 10% FCS [Hyclone Laboratories, Logan, UT]), .1 mM
Na pyruvate, 2MM L-glutamine, 0.05mM 2-ME, 100U/ml peni-
cillin, and 100pg/ml streptomycin for 24 h at 37°C in a humidified
5% COZ atmosphere . IL4 activity was determined by the ability
of supernatants from these cell cultures to support the incorpora-
tion of [3H]thymidine by CT4S cells (the kind gift ofW E. Paul,
National Institutes of Health [NIH], Bethesda, MD), exactly as
described (34) . Theconcentration of IL4 in samples was interpo-
lated from a standard curve generated using purified recombinant
murine IL4 . Based on this standard curve, the lower limit of de-
tectability for IL4 in the CT4S assay was 10 pg/ml . An aliquot
of each sample was preincubated with saturating concentrations
(75 Wg/ml) of purified 111111 (anti-murine IL4) mAb (35) for 45
min at 4'C before their addition to CT4S cells, to confirm that
[3H]thymidine incorporationwas 11,4 dependent . Purified recom-
Abbreviations used in this paper: [Caz'] ;, intracellular calcium coi.centra-
tion ; hGH, human growth hormone .
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binant murine 11,4 and 111111 mAbwereprovided byDr. K. Grab-
stein (Immunex Corp ., Seattle, WA) .
ImmunofluorescentFlow Cytometry.
￿
The following preparations
ofanti-murinemAbs were used for flow cytometric analysis : 500A.2
(reference 36)(CD3)hybridoma supernatant; FITC-conjugated 145-
2C11 (reference 37) (CD3) ; biotinylated H57-597 (reference 38)
(pan-a/(3 TCR) ; PE-conjugated GK1.5 (reference 39) (CD4) ; bi-
otinylated and FITC-conjugated 53-6.7 (reference 40) (CD8) .
500A.2 was kindly provided by Dr. J . Allison (University of
California, Berkeley, CA) . 145-2C11 and H57-957 were gifts of
Dr . A. Farr (University ofWashington, Seattle, WA) . Biotinylated-
53-6.7 was generously provided by Dr. B.J . Fowlkes (NIH) . The
remaining mAbs were purchased from Becton Dickinson (Moun-
tain View, CA). Single or two-color stainingof cellswasperformed
at 4'C in PBS/1% BSA/0.1% Na azide (staining buffer) with
saturating concentrations ofmAb as previously described (41) . PE-
conjugated streptavidin (Biomeda, Foster City, CA) was used for
detection of biotinylated mAb. For single or two-color analysis,
at least 3 x 10 3 lymphocytes per sample were analyzed using an
Epics Cinstrument (Coulter Electronics Inc., Hialeah, FL) equipped
with an argon laser. For three-color staining of CD3, CD4, and
CD8, cells in staining buffer were sequentially incubated for 15
min at4°C with 500A .2 hybridoma supernatant, FITC-conjugated
goat anti-hamster IgG (mouse and rat IgG absorbed) (Caltag
Laboratories, South San Francisco, CA), 10% normal rat serum,
biotinylated 53-6 .7, streptavidin-allophycocyanin (Biomeda), and
PE-conjugatedGK1.5 . Cells were extensively washed between each
step. Three-color analysis was performed on an Epics 753 instru-
ment (Coulter Electronics Inc.) using argon and helium-neon lasers.
At least 1 x 104 list mode-gated events were collected per sample.
Data was analyzed using MDADS and REPROMAN software
(Fred Hutchinson Cancer Research Center, Seattle, WA) .
In Vivo Treatment with Anti-IL4 mAh
￿
Starting at 1 mo of age,
transgenic mice or littermate controls were given three weekly in-
jections by tail vein of either 10 mg of purified anti-111,4 111311
mAb (35) in 0.25-0.5 ml of PBS (pH 7.4) or PBSalone. Mice were
sacrificed for analysis 1 wk after their final injection .
Caz' Analysis.
￿
Cells (101/ml in RPMI medium with 10%
FCS) were loaded with 3pg/ml ofthe acetoxymethyl ester ofindo-1
(42) for 45 min at 37°C in darkness, washed, and then stained
with saturating concentration of azide-free PE-conjugated CD4
and FITC-conjugated CD8mAb(Becton Dickinson) . After addi-
tional washing, cells were resuspended at 5 x 106/ml in RPMI
medium . Cytoplasmic free (intracellular) calcium concentration
([Ca"] i) was measured in individual cells by cytofluorometrically
determining their ratio of violet to blue emissions as previously
described (43) ; PE and FITC fluorescence were also simultaneously
determined . Measurements were performed at 37°C at a rate of
-1,000 cells/s using a Cytofluorograph 50H with a model 2150
computer (Ortho Diagnostic Systems, Westwood, MA) as previ-
ously described (43, 44) . When baseline [Ca2'] ; was established
after 2 min of cell flow, azide-free purified anti-CD3 mAb, 145-
2C11 (37), or ConA (Pharmacia Fine Chemicals, Piscataway, NJ)
were added to cells to final concentrations of10 or 25 ug/ml, respec-
tively, and flow was resumed. Computer analysis for [Ca'*Ii vs.
time andpercent-responding cells vs . time wasperformed as previ-
ously described (44) using the software Multitime (Phoenix Flow
Systems, San Diego, CA).
T Cell Activation. Round-bottom 96-well microtiter plates
(Corning Glass Works, Corning, NY)were incubated with either
mAb 145-2C11(37) (10 jig/ml in PBS),mAbH57-597 (38) (1:10,000
dilution (vol/vol) of ascites in PBS, provided by Dr. J . Ledbetter
(Oncogene, Seattle, WA), or with PBS alone for2 h at 37°C andthen washed five times with PBS. Spleen mononuclear cells (4 x
10°-2 x 10s) were added to wells in 0.2 ml ofCT4S medium and
incubated for 72 h at 37°C in a humidified atmosphere with 5%
C02 . All wells were pulsed for the last 12 h of incubation with
1 FcCi of [ 3H]thymidine . Cells were harvested onto glass fiber
filters and assayed for [ 3H)thymidine incorporation by liquid scin-
tillation counting . All assays were performed in triplicate .
Ig Isotype Analysis.
￿
Ig levels were determined by an isotype-
specific sandwich ELISA technique. The assays for IgGI, IgG3,
and IgE levels were performed as previously described (45) . IgG2a,
IgG2b, IgA, and IgM levels were similarly determined using ap-
propriate isotype-specific goat anti-mouse antibodies (Southern Bio-
technology Associates, Birmingham, AL) as first-step reagents to
coat the wells ofmicrotiter plates. After blocking with5% nonfat
dry milk, wells were incubated with plasma or isotype standards
(Southern Biotechnology Associates) diluted in PBS/3% BSA for
1 h, washed six times with PBS/0.5% Tween (Sigma Chemical
Co., St. Louis, MO), and then incubated with appropriate isotype-
specific, horseradish peroxidase-conjugated, goat anti-mouse an-
tibodies (Southern Biotechnology Associates) for 1 h . After six
washes with PBS/0.5% Tween, peroxidase-conjugated antibody
was detected usingTMB Microwell peroxidase substrate (Kirkegaard
& Perry Laboratories, Inc., Gaithersburg, MD) as specified by the
manufacturer. Plates were read on an ELISA reader (Dynatech
Laboratories, Inc., Alexandria, VA) . Data analysis of test samples
was performed as previously described (45) .
Results
Selective Intrathymic Expression of11,4 in Ick-IL4 Transgenic
Mice. To gain insight into the potential role of IL4 in
T-lineage cell development in vivo, transgenic mice were gener-
ated in which increased 11,4 expression was selectively tar-
geted to the thymus . Fig . 1 details the transgene expression
construct (Ick-IL4) in which a 3.2-kb Ick proximal promoter
segment (24, 25) was placed immediately 5' to a full-length
murine IL4 cDNA clone. The Ick proximal promoter has
previously been shown to direct the expression ofother trans-
genes in a thymocyte-specific manner (reference 25 and Perl-
mutter, R. M ., unpublished results) . The IL4 cDNA seg-
ment was embedded within the hGH gene since intronic
sequences appear to augment transgene expression (46) . By
positioning the cDNA 5' to the translation initiation codon
of the hGH gene, no growth hormone expression is observed
(data not shown) .
Three transgene-positive mice that expressed detectable
transgene-derived mRNA were obtained after injection of
the kk-IL4 construct . These founder animals, designated 1315,
4453, and 4475 displayed a distinct perturbation ofT -lineage
cell development that included (a) thymic hypoplasia ; (b) a
marked decrease in the number ofCD4+CD8+ thymocytes ;
NotI
plck (3 .2kb)
BamHI BarnHI
IL4cDNA
(0.7 kb)
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hGH gene (2 .1 kb)
(c) an absolute increase in the number of CD4 -CD8+
thymocytes ; (d) a decreased number of peripheral CD4+ T
cells ; and (e) the virtual absence of peripheral CD8+ T cells .
The estimated number of copies ofthe transgene in the 1315,
4453, and 4475 founders was 8, 5, and 5, respectively, based
on densitometry of tailDNA blots hybridized with an 11,4
cDNA probe (data not shown) . Since the transgene copy
number and the degree of perturbation of Tlineage cells in
these three founders were similar, this indicated that the par-
ticular integration site of the transgene did not have a
significant influence on the phenotype we observed. Described
below, in detail, are the results obtained with the 1315 founder
and six generations of its progeny .
Tissue expression of the Ick-II14 transgene was determined
by hybridization ofRNA blots with an IL-4 cDNA probe
(Fig. 2) . Transgene-encoded 114 transcripts, which contain
3' hGH sequences (Fig. 1), were significantly larger and readily
distinguished from the endogenous 0.7-kb IL4 transcripts
found in EL-4 cells. Two major sizes of transgenicIL4mRNA
were observed, presumably because of alternative splicing of
hGH intron sequences. Low levels of transgene transcripts
were detected in spleen (ti1-2% of that found in thymo-
cytes based on scanning densitometry) as well as LN tissue
Figure 2.
￿
Total RNA from tissues of kk-IL4 mice hybridized with an
IL-4 cDNA probe. All lanes were loaded with 10 ug. RNA from PMA-
stimulated EL4 cells, which express endogenous 11,4 gene transcripts, served
as a positive control.
NotI
Figure 1.
￿
Map of the kk-11,4 transgene con-
struct . The transcription start site of the kk pro-
moter is indicated by an arrow. The IL4 cDNA
segment is indicated by the solid rectangle. hGH
exon sequences are indicated by crosshatching .Table 1 . IL-4 Secretion ft/ml) by Unstimulated Cells from
(data not shown), but not in nonlymphoid tissues . Endoge-
nous RA transcripts were undetectableinRNA from all freshly
isolated tissues oftransgenic as well as littermate control mice
(Fig. 2, data not shown). Taken together, these results demon-
strated that kk-IL4 mice had increased expression of IL4
mRNA which was largely confined to the thymus .
The CT4S cell proliferation assay (34) was used to mea-
sure the amount ofbiologically active IL4 secreted by trans-
genic or control cells after short-term in .vitro culture. In-
Table 2 .
￿
Abundance of Thymocytes and Thymocyte Subpopulations in Ick-IL-4 and Littermate Control Mice
The absolute number of cells ( x 106) for each surface phenotype is indicated in parentheses .
creased expression of 1174mRNA by thymic tissue in kk-IL4
mice was paralleled by ILA secretion by thymocytes begin-
ning as early as day 18 of fetal life (Table 1) . Anti-IL4 mAb
completely neutralized this proliferative activity in the CTAS
assay, confirming that it was attributable to IL-4. The amount
of IL4 secretedby unstimulated thymocytes over a 24-h period
ranged from -25 to 70 pg/ml based on the activity ofpurified
rIL4 in the CT4S assay. In contrast, IL4 was not detected
in cultures of control thymocytes, or in cultures of spleno-
cytes or bone marrow cells from either transgenic or control
mice.
Perturbation of Thymocyte Development .
￿
The amount of
thymic tissue in Ick-IL4 mice was markedly reduced com-
pared with controls, with the loss of a clearly defined cor-
tical region (Table 2, Fig. 3A and B) . In virtually the entire
organ, thymocytes were found in a loosely packed pattern
characteristic of the normal medulla (Fig . 3 C and D) . This
reduction in thymocyte number compared with controls was
evident as early as day 3 after birth but not at day 16.5 of
fetal gestation (data not shown) . Consistent with these
findings, the proportion and absolute number of CD4
CD8' cells, a population which normally includes >75%
of thymocytes and is found mainly in the cortex (47), were
both markedly lower in transgenic compared with control
mice (Fig . 4 A, Table 2) . This decrease was accompanied by
an increased proportion of CD4 -CD8- , CD4+CD8 - , and,
particularly, CD4 -CD8' thymocytes . The CD4 -CD8+/
CD4+CD8 - thymocyte ratio in kk-IL4 mice was typically
greater than 1:1, and the absolute numbers ofCD4 -CD8'
cells exceeded those found in controls (Table 2) . A significant
proportion of CD4+CD8- and CD4 -CD8+ Ick-IL4 thy-
mocytes were also noted to have moderately reduced surface
expression of CD4 or CD8, respectively, compared with
thymocytes from controls (Fig. 4 A) .
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Total thymocytes
x 10,
CD4-CD8 -
Surface phenotype
CD4+CD8 -
(% of cells) thymocytes
CD4-CD8' CD4'CD8+
Exp . 1 : 3-wk-old mice
Ick-IL-4 29 8 (2)" 25 (7) 42 (12) 25 (7)
lck-IL-4 31 10 (3) 25 (9) 46 (14) 19 (6)
LM control 151 4 (6) 11 (17) 4 (6) 81 (122)
LM control 139 7 (10) 15 (21) 7 (10) 71 (99)
Exp . 2 : 9-wk-old mice
Ick-IL-4, PBS treated 28 9 (3) 28 (8) 33 (9) 30 (8)
Ick-IL-4, 11B11 treated 126 11 (14) 24 (30) 13 (16) 53 (67)
Ick-IL-4, 11B11 treated 110 9 (10) 24 (26) 12 (13) 55 (60)
LM control, PBS treated 106 4 (4) 8 (8) 3 (3) 85 (90)
LM control, 11B11 treated 88 4 (4) 10 (9) 2 (2) 84 (74)
Ick-IL-4 and Littermate Control Mice
Cell Type
- 11B11
mAb
'11B11
mAb
Exp . 1 : 6-wk-old mice
Ick-IL-4 thymocytes 29 <10
LM control thymocytes <10 ND
Ick-IL-4 splenocytes <10 <10
LM control thymocytes <10 ND
Ick-IL-4 bone marrow cells <10 <10
LM control bone marrow cells <10 ND
Exp . 2: 9-wk-old mice
Ick-IL-4 thymocytes 69 <10
Ick-IL-4 thymocytes 44 <10
LM control thymocytes <10 ND
Exp . 3 : 18-d gestation embryo
lck-IL-4 thymocytes 28 <10
LM control thymocytes <10 <10Figure 3 .
￿
Histologic sections of thymi from kk-IL4 mice or nontransgenic littermate controls after formalin fixation and staining with hematoxylin
and eosin . Low-power magnification x2 .5 ofa kk-IL4 thymus (A) demonstrating markedly decreased size and cellularity and loss ofa distinct cortical
region compared with a nontransgenic littermate thymus (B). Higher-power magnification (x25 of the kk-IL4 thymus (C) showing the loss of a
distinct cortical-medullary junction, and an overall loose-packing of cells characteristic of the normal medulla . In contrast, the thymus from a nontrans-
genic littermate (D) has a distinct cortical-medullary junction, with the cortical region densely packed with thymocytes ; the medullary region is located
in the upper right comer of the photomicrograph.
An increased proportion of lck-11,4 thymocytes expressed
surface TCR-ci//3 as assessed by two-color staining withCD3
and pan-ci//3TCRmAbs (Fig. 4 B), while the small numbers
(<5%) of thymocytes bearing TCR- ,y/S did not differ
significantly from that found in littermate controls (data not
shown) . To further characterize the lck-IL4 thymocyte popu-
lations that expressed surface TCR, three color staining for
CD3, CD4, and CD8 was performed . This revealed that most
CD4 -CD8+ lck-IL4 thymocytes expressed detectable sur-
face TCR, although a significant proportion of this popula-
tion had lower amounts of surfaceTCR compared with con-
trol CD4 -CD8+ thymocytes (Fig. 4 C, left) . Thymocytes
with this CD3+CD4 -CD8+ surface phenotype normally
first appear at the very end of fetal ontogeny (day 19) and
include CD4-CD8+ cells destined to emigrate from the
thymus (47) . In contrast, there was no significant increase
in the number-of CD3 -CD4 -CD8+ thymocytes, a popu-
lation which occurs earlier in fetal ontogeny (day 15), and
is apparently the direct precursor of CD3 -CD4+CD8+
thymocytes (48, 49) . CD4+CD8 - thymocytes from trans-
genic and control mice exhibited similar levels of CD3 ex-
pression (data not shown) . However, the proportion of
CD4+CD8+ thymocytes that were CD3` was strikingly in-
creased in lck-IL4 mice compared with controls (Fig . 4 C,
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left and right) . In agreement with previous work (36), the
amount ofCD3 staining on CD3+CD4+CD8+ thymocytes
from either transgenic or control animals was relatively low
compared with that found on most single-positive cells .
Reversal ofThymic Abnormalities in lck-IL4 Mice Treated with
Anti-IL4 Antibody . To confirm that IL4 secretion was
responsible for the phenotypic abnormalities ofT -lineage cells
in lck-IL4 mice, transgenic or control mice were treated for
1 mo with injections ofeither anti-IL4 mAb (111311) orPBS .
Transgenic mice that received anti-11,4 mAb had striking
increases in thymocyte number (Table 2) as well as partial
normalization of thymic architecture (data not shown) . The
composition of thymocyte subsets defined by surface expres-
sion ofCD4, CD8, andCD3 was also modified towards that
found in normal mice, after treatment with anti-IL4 but not
PBS (Fig. 4 C, Table 2) . There were no discernible effects
on the thymi of control mice as a result of treatment with
either anti-IL-4 or PBS. These results showed that the per-
turbation of thymic development observed in lck-IL4 mice
was critically dependent on the secretion of IL4 .
Peripheral TCells in lck-IL4 Mice .
￿
Phenotypic alterations
in the peripheral T cell compartment were also evident in
lck-IL4 mice . Most striking was the virtually complete ab-
sence of CD8+ T cells in the LN (Fig. 5 A), spleen, andA ,
￿
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Two- and three-color immunofluorometric analysis ofthymo-
cytes from kk-IL-4 and nontransgenic littermate (LM) control mice. Thymo-
cytes from 6-wk-old mice stained for (A) CD4 (GK1.5) vs . CD8 (104.21)
and (B) TCR-a/0 (H57-597) vs . CD3 (145-2C11) . (C) Three-color anal-
ysis of thymocytes from 9-wk-old mice, after in vivo treatment with PBS
or anti-IIr4 mAb (11B11), for CD4 (GK1.5) vs . CD3 (500A,2) on elec-
tronically gated cells positive for CD8 (104.21) .
peripheral blood (data not shown) . CD4+ T cells were
present at all ofthese sites, although in significantly reduced
numbers (Fig. 5, A and B) . Unlike CD4+CD8 - thymo-
cytes, the Ick-IL4 peripheral CD4+ T cell population had
surface levels ofCD4 comparable withT cells from controls
(Fig . 5 B) . CD4+ T cells in Ick-IL4 mice also displayed
normal levels ofTCR (Fig. 5 B) as well as CD5, CD45, and
Thy-1 (data not shown) .
Thymocyte and Peripheral T Cell Activation Is Significantly
Altered in Ick-IL4 Mice . To determine if the Ick-IL4 trans-
gene led to functional as well as phenotypic alterations of
T -lineage cells, individual thymocytes and peripheral T cells
were analyzed for activation-induced changes in [Cal+]; . In
all experiments, transgenic andcontrol cell populations with
A,
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Figure 5 .
￿
Two-color immunofluorescence analysis ofLN cells from kk-
IIr4 and nontransgenic littermate (LM) control mice for (A) CD4(GK1 .5)
vs . CD8 (104 .21) and (B) CD4 (GK1.5) vs . CD3 (500A.2) .
analogous patterns ofCD4 andCD8 surface expression were
directly compared. As shownin Fig. 6, thecalcium responses
of transgenic thymocyte populations after stimulation were
distinct from those observed in control cells: transgenic
CD4+CD8* thymocytes had strikingly greater increases in
mean [Ca211, compared with control CD4+CD8+ thymo-
cytes after treatment with anti-CD3 mAb (A), as well as Con
A or anti TCR-oi//3mAb (data not shown) . In contrast, the
calcium response of single-positive thymocytes to anti-CD3
mAb treatment was dramatically lower than that of control
populations (B and C) . CD4-CD8- transgenic and control
thymocytes both hadlow levels of response under these con-
ditions (data not shown) . When splenic CD4+ T cell popu-
lations were similarly analyzed, dramatically lower calcium
responses were observed in transgenic cells compared with
control cells after either anti-CD3 mAb or ConA treatment
(D) . Similar results were obtained using LN CD4+ T cells
(data not shown) . For all cell populations analyzed, the max-
imum percent of cells which gave a significant calcium re-
sponse paralleled the peak mean [Caz+]i achieved by these
cells (see legend to Fig. 6) . Transgenic peripheral CD8+ T
Table 3.
￿
Ig Isotype and IgG Subclass Levels (,ug/ml ± SEM) in Adult Ick-IL-4 (n = 12) and Littermate Control (n = 7) mice
Igm IgA IgE
Ick-IL-4
￿
644 ± 436
￿
1,510 ± 1,850
￿
2 .7 ± 0.1
LM control
￿
384 ± 200
￿
621 ± 484
￿
2 .5 ± 0.3
' p < 0.05 compared with LM control using the two-tailed Student's t test .
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IgG1 IgG2a IgG2b IgG3
1,010 ± 806
￿
268 ± 142'
￿
395 ± 108
￿
80 ± 60
882 ± 898
￿
142 ± 63
￿
330 ± 94
￿
35 ± 16
25 29 40 46 79 1 19
1 35 0 14 1 2300
200
0 0
U u300
0
m
200
100
0
￿
i .aa
O 2 4 6 8 0 2 4
Minutes
￿
Minutes
Figure 7 .
￿
Proliferative response of Ick-114 and littermatecontrol spleen
mononuclear cells to crosslinkingwith anti-CD3 orantiTCRa/(3 mAbs.
After 60 h, cultures were pulsed for 12 h with [3H]thymidine. Counts
were calculated as the mean ± SEM oftriplicate determinations. Lck-IL4
cell are indicated by stippled bars, and littermate control cells are indicated
by solid bars. The data havebeen normalized with respect to thepercentage
ofCD3+ cells found in the spleen mononuclear cell preparations. In the
experiment shown, 16% of Ick-114 cells and 31% of littermate control
cells were surface CD3+ . Similar results were obtained in two additional
experiments .
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B . CD4+CD8-
.
Anti-CD3
. . . .. . .. .LM Control
Or IL 4
ConA
---- LM Control
Ick IL-4
Figure 6 .
￿
[Ca2+]; in stimulated thymo-
cytes and splenic C]34+ T cells from
kk-IL4 and littermate (L44 control mice.
As described in MaterialsandMethods, cells
were sequentially loaded with indo-1 dye,
stained with PE-conjugated CD8 and
FITC-conjugated CD4 mAbs, and analyzed
for [Ca2+ li, using flow cytometry to gate
on cell populations expressing surface CD4
and/or CD8 . (A) CD4+CD8+, (B) CD4*
CD8 - , and (C) CD4-CD8* thymocytes
stimulated with anti-CD3 mAb (145-
2C11) . (D) Splenic CD4+ T cells stimu-
lated with either anti-CD3 mAb (145-
2C11) or Con A . Mean [Ca2+]i of all cells
analyzed vs . time is plotted in each histo-
gram . The maximum percentage oftrans-
genic ('IC) orlittermate control(LM cells
which responded with elevations of [Ca2+]i
by the end of the 8-min period was as
follows: (A) TG, 68% ; LM, 55% ; (B) TG,
12% ; LM, 77% ; (C) TG, 29% ; LM, 74% ;
(D) anti-CD3 ; TG, 13%, LM, 52% ; Con
A ; TG, 47%, LM, 75%.
cells were not present in sufficient numbers for them to be
similarly analyzed .
In contrast to their decreased TCR-mediated fluxes in
[Ca2+]i splenic T cells from Ick-IL4 mice appeared to
proliferate normally after cross-linking of their TCR-CD3
complexes with either anti-CD3 or anti-pan-ot/aTCR mAb
(Fig . 7) . In addition to their apparently normal proliferative
response, Ick-11A splenicT cells activated by anti-CD3mAb
also accumulated amounts ofIL-2 mRNA which were similar
to those in littermate control spleenT cells (data not shown) .
Additional Abnormalities in Ick-IIr4 Mice .
￿
LA-IL-4 mice
were remarkably susceptible to parasitic infection. Conven-
tionally housed transgenic mice, but not controls, invariably
developed severe intestinal infection with the pinworm Syphacia
obvelata (50) . Megacolon, rectal prolapse, and cecal perfora-
tion were frequent findings. Most severely infected mice died
between 6 and 12 wk of age. In contrast, infection of con-
ventionally housed Ick-1114 mice with mouse hepatitis virus
only rarely caused significant disease . Since IL4 has been shown
to increase IgE and IgG1 isotype production by activated B
cells in vitro (8), and to be directly involved in promoting
IgE production in vivo during parasitic infection (11, 12),
we determined the concentrations of these and, for compar-
ison, other Ig isotypes in the circulation ofpinworm-infected
Ick-IL4 mice and littermate controls (Table 3) . There were
no significant differences between transgenic and control mice
in their plasma levels of IgM, IgA, IgE, IgG1, IgG2b, or
IgG3 . An unexpected finding was that IgG2a levels were
significantly higher in infected Ick-IL4 mice compared with
controls. This observation may reflect the higher antigenic
load experienced by Ick-IL4 mice. These results, which sug-
gested that B cell function was not grossly perturbed by the
IL4 transgene, were consistent with the normal histologic
appearance of lymphoid follicles and the normal numbers of
peripheral B220+ B cells found in Ick-IL4 mice (data notshown). Since IL4 has also been shown to act as a growth
factor for mast cells (5), we histologically examined these trans-
genic mice for increased mast cell numbers using a Giemsa
stain. However, we failed to find significant increases in mast
cell abundance in any organs of kk-11A mice, including the
skin (data not shown).
Discussion
114 has previously been shown to promote the growth
of isolated thymorytes including fetal and adult CD4-
CD8 - cells, adult CD4+CD8 - and CD4-CD8+ cells, but
not CD4+CD8+ cells (15-21). In vitro studies using mu-
rine CD4-CD8- or human CD4 - CD8 - CD3 - CD1 - thy-
mocytes suggest that IL4 preferentially promotes differenti-
ation of double-negative or CD8+ y/b Tlineage cells (16,
21). Consistent with this interpretation, incubation of iso-
lated double-positive or single-positive TCRci/S+ thymo-
rytes with 114 does not significantly alter their surface ex-
pression of CD4, CD8, or CD3 (Lewis, D., unpublished
observations). These results contrast with those obtained in
our in vivo model, which demonstrate a profound influence
of IL4 on the abundance, surface phenotype, and TCR-
mediated activation of thymocytes, particularly TCRu/Q+
cells at later stages of maturation, and on the ability of ma-
ture thymorytes to successfully colonize the periphery. We
conclude that proper interactions between cytokines and the
thymic microenvironment are crucially important in regulating
multiple aspects of T cell development.
11,4 expression by normal murine fetal thymorytes is highest
at day 15 ofgestation,when the predominant thymocyte popu-
lation is CD4 - CD8 - , but rapidly declines by day 16, be-
coming undetectable from day 18 of gestation onward (13).
This suggests a potential physiologic role for IL -4 in early
thymic development. In preliminary experiments, we have
examined the effects ofthe Ick-IL4 transgene on fetal thymic
ontogeny at day 16 .5-17 of gestation and have found no
significant differences between transgenic and control thymo-
cytes with respect to CD3, CD4, or CD8 surface expression
(data not shown) . Further, no significant differences were ob-
served in the percentage of thymorytes bearing TCR--y/S,
or in their surface expression of Thy-1, CD5, or CD45. IL4
secretion by Ick-11,4 but not control thymorytes is detect-
able as early as day 18 of gestation (Table 1), and it is likely,
based on the normal ontogeny of expression of the endoge-
nous proximal Ick promoter, that thymocytes express the
lck-IL4 transgene beginning as early as day 14 of gestation
(reference 51; Lewis, D., and R. Perlmutter, unpublished ob-
servations) . These findings argue that increased intrathymic
expression of 11,4 has little discernible impact on T cell de-
velopment before the appearance of double-positive thymo-
cytes. In contrast, the development of double-positive and
TCRu/a-bearing single-positive thymocytes is dramatically
affected by in situ IL4 productionin adult mice. These results
suggest that the progressive decrease in IL4 expression by
thymorytes which occurs during late fetal ontogeny may be
critical for subsequent normal T cell development .
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The thymi ofkk-IL4 mice lacked a clearly defined cortex,
a region which in normal mice predominantly contains double-
positive thymocytes (47). Cortical CD4+CD8+ thymocyte
depletion is also a prominent feature of thymi from mice that
have been physiologically stressed or treated with glucocor-
ticoids. However, under these conditions the CD4+CD8 - /
CD4- CD8+ single-positive thymocyte ratio, which nor-
mally is -2-3:1, remains unchanged (52, 53). In contrast,
in kk-IL4 mice this ratio was typically 1:1 or less, reflecting
an absolute increase in the number of CD4 - CD8+ thymo-
cytes. Hence, the alterations observed in thymic development
in kk-IL4 mice, which clearly depended on the secretion of
IL4 (Table 2, Exp. 2; Fig. 4 C), are unlikely to be simply
the result of systemic stress.
The finding that CD4+CD8+ thymocytes had increased
TCR surface expression in kk-11A mice is particularly
noteworthy, since no cytokine has previously been shown to
mediate this effect. Although the mechanism by which 11,4
increases surface TCR expression on double-positive cells re-
mains to be determined, the results of treatment of lck-IL4
mice with anti-IL4 mAb clearly show that this effect is de-
pendent on the actual secretion of 114. Similar increases in
surface TCR expression by double-positive thymocytes have
also been observed after in vivo treatment of normal mice
with anti-CD4 but not anti-CD8 mAb (54, 55), or when
normal thymorytes are incubated in vitro in suspension but
not as tissue fragments (55, 56). In both cases, a posttransla-
tional mechanism, in which assembled CD3-TCR complexes
are more efficiently transported from the endoplasmic retic-
ulum to the cell surface, appears to be involved (55). These
findings have led to the proposal that the thymic microen-
vironment may provide a signal through the CD4 molecule
of CD4+CD8+ thymorytes which attenuates the surface ex-
pression of TCR by these cells (55) . We have found that the
inclusion of IL4 in suspension cultures of normal thymo-
cytes does not further augment surface TCR expression by
double-positive thymocytes (Lewis, D., unpublished obser-
vations), suggesting that, like anti-CD4 mAb treatment, an
intact thymic microenvironment is required for this 11,4-medi-
ated effect. It remains to be determined whether an altered
CD4-mediated signal in Ick-IL4 double-positive thymocytes
is also responsible for their increased TCR expression, or
whether thymi from kk-IL4 mice have decreased surface ex-
pression of class II MHC, the presumed physiologic surface
ligand for CD4 within the thymus (57).
An increasing body of evidence indicates that engagement
of TCR-a/(3 on CD4+CD8+ thymocytes by self-MHC,
presumably as part of a complex with self-antigen peptides,
is critical both for the development of T cells with receptors
capable of recognizing foreign antigen-self-MHC complexes
(positive selection) as well as the deletion of T cells bearing
TCR with potentially harmful self-reactivity (negative se-
lection; for review see reference 58) . The signals by which
TCR engagement leads to either positive or negative selec-
tion of thymorytes remain poorly understood. In a model
for negative selection using cultured fetal thymus lobes,
CD4+CD8+ thymocytes which mobilize calcium after treat-ment with anti-CD3 or antiTCR-ot/,6 mAbs are also elimi-
nated by these mAbs during organculture (59-61). This corre-
lation between TCR-mediated calcium fluxes and in vitro
deletion also provides a plausible explanation for the deple-
tion of CD4+CD8+ thymocytes observed in all lines of
lck-IL4 mice. Lck-IL4 CD4+CD8+ thymocytes, by virtue
of their increased mobilization of [Ca2 +]i after TCR-CD3
complex engagement, might also be more proneto intrathymic
deletion than normal double-positive thymocytes.
The expression of IL-4 intrathymically exerted different
effects on mature CD4+CD8 - as compared with CD4 -
CD8+ Tlineage cells. Only CD4 - CD8+ thymocytes were
increased in absolute numbers in these thymi, while, in con-
trast, only CD4' and not CD8+ T cells were found in the
peripheral compartment. This suggests that CD4 - CD8+
thymocyte emigration was blocked in lck-IL4 mice, or that
ifemigration occurred, these cells failed to proliferate at pe-
ripheral sites. A significant, but less severe, decrease in the
emigration of CD4+CD8` thymorytes might also account
for the reduced numbers of peripheral lck-IL4 CD4+ T cells
we observed. Although the mechanisms involved in the
emigrationof single-positive thymorytes into the circulation
are poorly understood, our results suggest that cytokines such
as IL-4 can differentially regulate this process in CD4+CD8'
and CD4 - CD8+ T lineage cells. The observation that IL-4
in vitro is significantly more effective in promoting the growth
of CD4 - CD8+ compared with CD4+CD8' thymocytes
(17) indicates that these two populations may differ intrinsi-
cally in their responses to IL-4 by other criteria as well.
Peripheral T cells as well as mature TCR-00-bearing
single-positive thymorytes from lck-IL4 mice were markedly
defective in their mobilization of calcium in response to anti-
CD3 mAb or the mitogen, Con A (Fig. 6). However, kk-11,4
T cells appeared to proliferate as well as control cells in re-
sponse to anti-CD3 or anti-TCRa/(3 mAb (Fig. 7). Although
thymidine incorporation by lck-IL4 splenocytes was lower
than that by splenocytes from littermate controls, this de-
crease was proportional to the lower percentage of periph-
eral T cells found in this transgenic population (see legend
to Fig. 7). The mechanism(s) responsible for this relatively
selective defect in proximal signal transduction by mature
lck-IL4 Tlineage cells remain to be defined. T cell prolifera-
tion after activation via the TCR-CD3 complex has previ-
ously been shown to be dependent on the interaction of IL2
with its specific high-affinity receptor (62), suggesting that
this interaction occurred normally in Ick-IL4 peripheral T
cells. This interpretation is supported by the fact that 11,2
mRNA accumulation in lck- IL4 cells activated with either
anti-CD3 mAb, Con A, or ionomycin and PMA was at least
equal to that observed in littermate controls (data not shown).
Therefore, it is possible that lck-IL4 and peripheral T cells
may be capable of IL2 productionby a calcium-independent
pathway. Since a calcium-independent pathway for IL2 produc-
tion has previously only been described in murine T cell hy-
bridoma line variants or mutants deficient in CD3-,q chains
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(63, 64), it will be of interest to confirm that TCR-mediated
proliferation of mature kk-IL4 Tlineage cells is calcium in-
dent and, ifso, whether these cells have decreased CD3-,q
expression as well as reduced activation-induced phosphoin-
soitide hydrolysis. Alternatively, mature lck-IL4 thymocytes
and T cells may be more susceptible to inhibition of TCR-
mediated calcium mobilization by anti-CD4 or -CD8 mAb,
which were used to identify cell subsets in these assays, than
are control cells. Such inhibition of TCR-mediated calcium
mobilization by anti-CD4 mAb has previously been observed
in certain T cell clones (65).
An unexpected finding in lck-IL4 mice was their suscep-
tibility to severe infection by the pinworm Syphacia obvelata .
Previous adoptive transfer studies with nude mice have indi-
cated that Tlineage cells may be critical for the control of
this pathogen (50) . In other murine models, CD4+ T cells
have also been shown to be important for the control ofother
parasitic infections, including Nippostrongylus and Leishmania
(66, 67). Therefore, it is possible that the generally low
numbers of peripheral lck-IL4 T cells, as well as their ap-
parent functional defects, could both contribute to the vul-
nerability of lck-IL4 mice to parasitic infection. It remains
to be shown that kk-IL4 T cells have defective antigen-specific
responses in vitro or in vivo.
While preparing this manuscript we became aware ofdata
by Tepper et al. (68) showing that an IL4 transgene under
the control ofthe u H chain enhancer results in the increased
expression of 11,4 by -T- as well as B-lineage cells. These mice
demonstrate most of the phenotypic alterations in Vintage
cells we have observed in lck-IL4 mice, confirming that these
results are attributable to the IL4 gene product itself. How-
ever p. H chain enhancer-IL4 transgenic mice differ from
lck-11,4 mice in that their serum levels of IgG1 and IgE iso-
types are increased, and their skin and eyes are infiltrated with
large numbers ofmast cells. Our failure to observe these effects
on nonTlineage cells in lck-11,4 mice, despite their consti-
tutive intrathymic production ofsignificant amounts of IL-4,
indicates that this cytokine acts locally rather than systemi-
cally, even when it is overexpressed in vivo. A soluble form
of the IL4R has recently been identified in the circulation
ofmice (69, 70). Soluble IL4R couldpotentially bind excess
11,4 produced in tissues and prevent the occurrence of sys-
temic effects. Recent studies by Maliszewski et al. (45) have
shown that soluble IL4R can inhibit IL4-mediated effects
in vitro. Our results suggest that mechanisms of this type,
limiting the effects of IL4 at a distance, are of considerable
importance. In the absence ofsuch regulation, peripheral IL4
production in response to inflammatory stimuli could poten-
tially compromise intrathymic T cell development. Hence,
it will be of interest to determine whether the levels of cir-
culating IL4-IL4R complexes are increased in lck-IL4 mice,
and whether the production of soluble receptor is upregu-
lated in response to the constitutive synthesis of 11,4 in-
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